Academic Editor: Peter A. McCullough
The benefit of complete revascularization in elderly patients with non-ST
elevation myocardial infarction (NSTEMI), and multivessel disease remains debated
(MVD). The aim of our study was to determine the current long-term prognostic
benefit of complete revascularization in this population. A retrospective cohort
study of 1722 consecutive elderly NSTEMI patients was performed. Among the study
participants 30.4% (n = 524) were completed revascularizated and in 69.6% (n =
1198) culprit vessel only revascularization was performed. A propensity score
analysis was performed and we divided the study population into two groups:
complete revascularization (n = 500) and culprit vessel only revascularization (n
= 500). The median follow-up was 45.7 months, the all cause mortality (44.5% vs
30.5%, p